Flushing, NY, United States of America

Abu T M Serajuddin

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: St. John's University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abu T M Serajuddin. Retrieved from https://idiyas.com/inventor/abu-t-m-serajuddin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Abu T M Serajuddin

Introduction

Abu T M Serajuddin is an accomplished inventor based in Flushing, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. His innovative approach has led to the creation of a unique patent that addresses challenges in nanoparticle stabilization.

Latest Patents

Abu T M Serajuddin holds a patent for "Sugar ester nanoparticle stabilizers." This invention involves the preparation of solid dosage forms containing nanoparticles, where sugar esters serve as stabilizers. These stabilizers prevent the agglomeration of nanoparticles during the preparation process and allow for the restoration of the original nanoparticle size upon redispersion in aqueous media.

Career Highlights

Abu T M Serajuddin is affiliated with St. John's University, where he contributes to research and development in the pharmaceutical sciences. His work focuses on enhancing the efficacy and stability of drug formulations through innovative techniques.

Collaborations

Abu T M Serajuddin collaborates with Hetalben N Prajapati, working together to advance their research in nanoparticle technology and its applications in pharmaceuticals.

Conclusion

Abu T M Serajuddin's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving drug formulation techniques. His work continues to influence the development of effective solid dosage forms.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…